Cargando…
Economic evaluation of remifentanil-based versus conventional sedation for patients with an anticipated mechanical ventilation duration of 2–3 days in Germany
Autores principales: | Al, MJ, Martin, J, Bakker, J, Welte, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088644/ http://dx.doi.org/10.1186/cc6494 |
Ejemplares similares
-
Remifentanil vs conventional sedation in The Netherlands: a pharmacoeconomic model analysis
por: Al, M, et al.
Publicado: (2007) -
Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
por: Karabinis, A, et al.
Publicado: (2004) -
Remifentanil versus sufentanil continuous infusion for sedation in mechanically ventilated patients
por: Costa, G, et al.
Publicado: (2005) -
Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients
por: Van den Bosch, J, et al.
Publicado: (2011) -
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
por: Al, Maiwenn J, et al.
Publicado: (2010)